Healthtech Startups

Mindful Care provides mental health services, offering information and treatment for conditions such as bipolar disorder. It serves individuals seeking psychiatric and mental health care.

1 investor

1 investor

Mindful Health Solutions is a provider of behavioral health care specializing in advanced psychiatric treatments including Transcranial Magnetic Stimulation (TMS), esketamine nasal spray, IV ketamine therapy, and emerging psychedelic therapies, primarily for treatment-resistant depression. Operating 21 clinics across California, Texas, and Washington, the company employs board-certified psychiatrists and uses data-driven protocols to deliver personalized mental health care.

1 investor

MindHelp A provides digital mental health screening and assessments for conditions including ADHD, anxiety, depression, and bipolar disorder, with consultations from GMC-licensed psychiatrists and medical doctors. The platform offers clinically-validated assessments and psychiatric coaching for individuals seeking mental health evaluation and support.

1 investor

MindBytes develops digital health tools and patient education solutions designed in collaboration with healthcare stakeholders and based on scientific evidence. The company serves healthcare organizations, pharmaceutical companies, and patients seeking evidence-based digital interventions to improve health outcomes.

1 investor

Mindoo builds AI agents that handle routine administrative and patient-facing tasks for healthcare teams, including patient intake, answering calls, scheduling, and post-visit follow-ups. It is designed for clinics and hospitals, with audit trails, consent handling, and region-specific data protections.

1 investor

Mindset Medical develops medical-grade software that uses remote photoplethysmography (rPPG) and deep learning to measure vital signs such as heart rate and respiratory rate through the camera on a patient's own smartphone, tablet, or computer. The contactless technology is aimed at healthcare platforms, health systems, health plans, and employers for telemedicine, remote patient monitoring, and population health use in the United States.

1 investor

Mindspan provides cognitive care through at-home screening and in-clinic evaluation by board-certified neurologists, reducing typical 18-month wait times to weeks for patients with memory changes, mild cognitive impairment, Alzheimer's disease, and other dementias. The platform combines diagnostic assessments with personalized treatment plans and ongoing family-centered support to address cognitive health conditions.

1 investor

Mine Iyakuhin operates the MineDrug drugstore and Mine Pharmacy retail chains, selling pharmaceutical and drugstore products through stores in Tokyo and neighboring prefectures. The company runs a network of retail pharmacies and drugstores in the Tokyo metropolitan area.

1 investor

Minerva Neurosciences is a clinical-stage biopharmaceutical company developing product candidates for central nervous system disorders. It focuses on designing clinical trials with endpoints tied to patient benefit.

1 investor

Minerva Surgical is a women's health medical device company focused on technologies for conditions such as heavy menstrual bleeding, offering alternatives to hysterectomy. It provides support to clinical teams using its products.

1 investor

Mingle Health provides quality management and Medicare quality reporting solutions for medical practices and healthcare organizations. Formed in 2018 from the merger of Mingle Analytics and SilverVue, the company serves clients across the United States with data-driven healthcare software and services.

1 investor

SCHOTT MINIFAB provides contract design, development, and manufacturing services for life science research and diagnostic consumables, including cleaned and coated substrates for in vitro diagnostics and research applications. It specializes in microarray, microfluidic, and injection molding techniques and serves product developers in the diagnostics and life science tools market, with production in the United States, Germany, and Australia.

1 investor

Miniique is a cloud-based electronic medical records system designed for veterinary hospitals that consolidates appointment scheduling, clinical notes, billing, and management operations. The platform serves veterinary clinics of all sizes across Japan with an intuitive interface designed for users with limited IT experience.

1 investor

1 investor

Minset builds an AI-driven revenue cycle management platform for healthcare providers, aimed at reducing claim denials and getting practices paid faster. It positions itself as an autonomous alternative to manual, staff-heavy billing processes.

1 investor

Miphic provides imaging-based diagnostic screening of mitochondrial function to identify drug efficacy and personalized treatment options for cancer, neurodegenerative disease, diabetes, and aging-related conditions. The platform screens up to 96 conditions simultaneously to support drug discovery, personalized medicine selection, and metabolic research.

1 investor

MiraBiologics is a Japanese biopharmaceutical drug discovery company that uses its LassoGraft Technology to graft cyclic peptides onto scaffold proteins for the development of novel biologics. It pursues collaborative R&D partnerships to create innovative biopharmaceuticals.

1 investor

Miracle unifies data from multiple clinical trial platforms to provide automated insights for healthcare professionals in biopharma. The company aims to accelerate clinical trial execution and help bring new therapeutics to market more efficiently.

1 investor

Mirada develops medical imaging software solutions that personalize image-guided cancer treatment to improve patient outcomes. The company combines scientific advancement, technical innovation, and clinical expertise to accelerate cancer care delivery.

1 investor

MFC Co., Ltd. manufactures active pharmaceutical ingredients (APIs) and key starting materials, and conducts R&D and mass production in pharmaceuticals and materials. Using high-purity crystallization technology, it develops and supplies Statin-class APIs such as TBFA and TPPBr, focusing on domestic production of imported pharmaceutical ingredients in South Korea.

1 investor

Mirae is a mobile application that helps people with inflammatory bowel disease understand their condition, track clinical and daily experience data, and prepare for conversations with healthcare providers. The app combines patient-reported symptoms and clinical information to give people with IBD a clearer picture of their disease without replacing clinical judgment.

1 investor

Miraka provides clinician-led cardiac care delivered at home, using continuous real-time monitoring of biometrics such as heart rhythm, blood oxygen, and blood pressure to detect emerging risks and escalate treatment early. It serves cardiac patients between hospital visits, aiming to reduce hospital readmissions, and works via physician referrals at health systems.

1 investor

Miramoon Pharma develops neuroprotective small molecule therapies targeting degenerative disorders including ophthalmology, skeletal and cardiac muscle diseases, and central nervous system conditions. The company was spun out from the University of the Basque Country and Biogipuzkoa Health Research Institute.

1 investor